Verition Fund Management’s Biofrontera BFRI Stock Holding History

Verition Fund Management’s Portfolio BFRI Stock Details BFRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,795	Closed	-$420K	–	2723
2021 Q4	$420K	Buy	+2,795	New	+$306K	﹤0.01%	1799

Other funds holding BFRI

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Verition Fund Management's BFRI Position: Q1 2022 in Review

Verition Fund Management sold out of Biofrontera (BFRI) in Q1 2022, closing a stake of 2,795 shares — an estimated $420K sold.

Verition Fund Management first reported a position in BFRI in Q4 2021 and held it in 1 quarter. The position peaked at $420K in Q4 2021. 12 funds tracked by Wall St. Rank hold BFRI as of Q1 2022.

Verition Fund Management reported no remaining Biofrontera position as of Q1 2022 after selling out during the quarter.
Verition Fund Management sold 2,795 Biofrontera shares in Q1 2022, an estimated $420K.
Verition Fund Management first reported a position in Biofrontera in Q4 2021 and held it in 1 quarter.
Verition Fund Management's Biofrontera position peaked at $420K in Q4 2021.
12 funds tracked by Wall St. Rank held Biofrontera as of Q1 2022.

Based on Verition Fund Management's 13F filing for Q1 2022, filed 13 May 2022.